Adagene

Price & Volume

Track all markets on TradingView

Stats

See more
52W Range
$1.74-$4.38
Market Cap
$108.4M
Shares Short
65,276

Financials

See more
Revenue (12 Mos)
$815,746
Revenue Growth (YoY)
-84.8%
Gross Profit (12 Mos)
$10.1M
Diluted EPS
-$0.72

News

See more

Yahoo Finance • 12 months ago

Adagene Inc.'s (NASDAQ:ADAG) market cap surged US$34m last week, retail investors who have a lot riding on the company were rewarded

Yahoo Finance • last year

Adagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 at SITC 2023

Yahoo Finance • last year

Adagene Announces Poster Presentation on Optimal Dose Selection for Masked Anti-CTLA-4 SAFEbody® ADG126 at Upcoming Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Yahoo Finance • 2 years ago

Adagene Presents Clinical Data for Anti-CTLA-4 SAFEbody® ADG126 Reinforcing Best-in-Class Safety Profile at Repeat Doses and Showing Early Efficacy Profile in Advanced/Metastatic Solid Tumors

About

CEO
Dr. Peter P. Luo Ph.D.
CFO
Mr. Man Kin Tam M.B.A.
Address
Building C14, Suzhou, China, 215123
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
174